Negative Symptoms and Cognitive Impairments in Schizophrenia: Two Key Symptoms Negatively Influencing Social Functioning-Reference-Cited by-同舟云学术

Negative Symptoms and Cognitive Impairments in Schizophrenia: Two Key Symptoms Negatively Influencing Social Functioning

Published:2018 Issue:2 Volume:61 Page:091-102
ISSN:1346-8049
Container-title:Yonago Acta Medica
language:en
Short-container-title:Yonago Acta Med.

Author:

Kaneko Koichi¹

Affiliation:

1. Division of Neuropsychiatry, Department of Brain and Neurosciences, School of Medicine, Tottori University Faculty of Medicine, Yonago 683-8503, Japan

Publisher

Tottori University Faculty of Medicine

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/yam/61/2/61_2018.06.001/_pdf

Reference76 articles.

1. 1 Leucht S, Pitschel-Walz G, Abraham D, Kissling W.Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials. Schizophr Res. 1999;35:51-68. PMID: 9988841

2. 2 Keefe RSE, Sweeney JA, Gu H, Hamer RM, Perkins DO, McEvoy JP, et al.Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison. Am J Psychiatry. 2007a;164:1061-71. PMID: 17606658

3. 3 Keefe RS, Bilder RM, Davis SM, Harvey PD, Palmer BW, Gold JM, et al.Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial. Arch Gen Psychiatry. 2007b;64:633-47. PMID: 17548746

4. 4 Green MF, Nuechterlein KH.Should schizophrenia be treated as a neurocognitive disorder?. Schizophr Bull. 1999;25:309-19. PMID: 10416733

5. 5 Green MF, Kern RS, Braff DL, Mintz J.Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”?. Schizophr Bull. 2000;26:119-36. PMID: 10755673

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between psychopathological symptoms and dimensions in inpatients with schizophrenia: A network analysis;Schizophrenia Research;2024-10

2. ℛSCZ: A Riemannian schizophrenia diagnosis framework based on the multiplexity of EEG-based dynamic functional connectivity patterns;Computers in Biology and Medicine;2024-09

3. Impact of psychopathology on day-to-day living in patients with schizophrenia: A network analysis;Comprehensive Psychiatry;2024-08

4. Intermittent Theta Burst Stimulation Combined with Cognitive Training to Improve Negative Symptoms and Cognitive Impairment in Schizophrenia: A Pilot Study;Brain Sciences;2024-07-08

5. Effects of serum inflammatory factors, health index and disease activity scores on ankylosing spondylitis patients with sleep disorder;World Journal of Psychiatry;2024-06-19